An interventional study of Online Motivation Enhancing Intervention in Schizophrenia Prodromal, SCHIZOPHRENIA 1 (Disorder) and Psychosis, sponsored by University of Alabama at Birmingham. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-13.
Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 20 studies in Schizotypal Personality Disorder with a site in United States — 3 open to participants now, 5 under way, none of them phase 3. Schizotypal Personality Disorder · United States.
Among the 20 studies in Schizotypal Personality Disorder with a site in United States, this one is the 6th largest by planned enrollment of the 17 interventional ones that give a count, is the only one that started in 2026, is one of 12 with no phase, and was the 20th registered.
49 studies on the registry are indexed under Schizotypal Personality Disorder; 12 are open to participants now.
Browse Schizotypal Personality Disorder studies →3 of the 20 studies in Schizotypal Personality Disorder with a site in United States are open now. Recruiting first, the newest first:
Northwell Health · Sites in United States
Ages 14–20
Ohio State University · Sites in United States
Ages 12–25
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 9 Schizotypal Personality Disorder studies recruiting now, 1 sets no upper age limit and 8 stop at 75 or younger; 5 take children under 18; 2 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
20 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 4 · Phase 4 1
First in 1995; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is above the median of 54 across 41 interventional studies indexed under Schizotypal Personality Disorder.
Median enrollment 45 across the 17 interventional studies, 52 across the 2 observational. Of the 12 that completed or were terminated, 2 (17%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 20 have an industry lead sponsor. The 10 most frequent:
University of Alabama at Birmingham is the lead sponsor of 1,422 studies on the registry; 277 are open to participants now.
Of its 164 completed or terminated interventional studies of FDA-regulated products, 130 (79%) have results posted.
University of Alabama at Birmingham has 1 study filed under Schizotypal Personality Disorder — fewer than ten, so there is no comparison to draw.
2 of the studies in Schizotypal Personality Disorder with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04338152University of California, Los AngelesFamily-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial | 2026-12-30 |
| NCT05877716University of MinnesotaEPI-MINN: Targeting Cognition and Motivation - National | 2027-03-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 20 studies in Schizotypal Personality Disorder with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Participants will complete one online intervention lasting 12 weeks. Each week, they will be asked to complete a 20-30 minute session online. The intervention is targeting improved mood and positive affect in order to support increases in motivation and goal-directed behavior. Before and after the intervention, participants will be asked to complete measures to assess symptoms, mood, and behavior.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: Online Motivation Enhancing Intervention
This is a online intervention that will ask participants to review and complete 30 minutes of material each week.
Brief Negative Symptom Scale
Interview measure of motivation and pleasure
Time frame: immediately before and after the intervention
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Dec 2026; primary completion for May 2028, 17 months later.
Of 20 interventional studies with no phase under Schizotypal Personality Disorder, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 59. This study's planned 17 months is below that.
Start moved once since we started tracking on Sep 25, 2026: Aug 2026 → Dec 2026, on Oct 13, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Schizotypal Personality Disorder →
University of Alabama at Birmingham →